D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
PUT
Live Nation Entertainment
LYV
$42.9B
| $24.6M | 0.02% |
162,500
-31,100
| -16% | -$4.28M |
|
852
Packaging Corp of America
PKG
$22.2B
| $24.5M | 0.02% |
129,853
+53,260
| +70% | +$10.1M |
|
853
PUT
Tapestry
TPR
$30.3B
| $24.4M | 0.02% |
278,300
-378,000
| -58% | -$28.6M |
|
854
Burlington
BURL
$23.4B
| $24.4M | 0.02% |
104,847
+21,173
| +25% | +$5.03M |
|
855
CALL
HCA Healthcare
HCA
$90.6B
| $24.3M | 0.02% |
63,400
+3,100
| +5% | +$1.12M |
|
856
Revolution Medicines
RVMD
$38.5B
| $24.3M | 0.02% |
+660,132
| New | +$25.4M |
|
857
Middleby
MIDD
$6.01B
| $24.2M | 0.02% |
168,377
-22,865
| -12% | -$3.22M |
|
858
Kinsale Capital Group
KNSL
$8.58B
| $24.2M | 0.02% |
49,962
-14,875
| -23% | -$6.94M |
|
859
PUT
Thermo Fisher Scientific
TMO
$214B
| $24.2M | 0.02% |
59,600
+55,000
| +1,196% | +$23M |
|
|
COOP
860
DELISTED
Mr. Cooper
COOP
| $24.2M | 0.02% |
161,863
+137,212
| +557% | +$17.6M |
|
861
Teck Resources
TECK
$28.2B
| $24.1M | 0.02% |
596,575
-6,315,804
| -91% | -$228M |
|
862
Tractor Supply
TSCO
$16.3B
| $24.1M | 0.02% |
+456,622
| New | +$23.4M |
|
863
Bristol-Myers Squibb
BMY
$129B
| $24M | 0.02% |
518,222
-240,348
| -32% | -$11.8M |
|
864
Myriad Genetics
MYGN
$476M
| $24M | 0.02% |
4,511,497
+1,988,879
| +79% | +$11.7M |
|
865
PUT
Nutrien
NTR
$33.9B
| $23.9M | 0.02% |
410,000
-56,000
| -12% | -$3.16M |
|
|
OPTU
866
Optimum Communications Inc
OPTU
$298M
| $23.8M | 0.02% |
11,130,938
-83,039
| -0.7% | -$195K |
|
867
Moog Inc Class A
MOG.A
$12.4B
| $23.8M | 0.02% |
131,598
+58,953
| +81% | +$10.3M |
|
868
CALL
TJX Companies
TJX
$179B
| $23.7M | 0.02% |
192,000
+73,900
| +63% | +$9.37M |
|
869
PUT
Telus
TU
$17.4B
| $23.7M | 0.02% |
1,475,000
+800,000
| +119% | +$12.4M |
|
870
Evolent Health
EVH
$371M
| $23.7M | 0.02% |
2,104,373
+225,373
| +12% | +$2.07M |
|
871
Canadian Imperial Bank of Commerce
CM
$106B
| $23.6M | 0.02% |
332,154
+259,271
| +356% | +$16.7M |
|
872
CALL
Devon Energy
DVN
$51.3B
| $23.6M | 0.02% |
741,400
+243,400
| +49% | +$7.75M |
|
873
Alkermes
ALKS
$8.11B
| $23.5M | 0.02% |
820,096
+351,615
| +75% | +$10.5M |
|
874
PUT
Wells Fargo
WFC
$254B
| $23.4M | 0.02% |
292,600
-329,100
| -53% | -$23.7M |
|
875
Estee Lauder
EL
$30.4B
| $23.4M | 0.02% |
289,512
-283,214
| -49% | -$18.2M |
|
Similar funds
D.E. Shaw & Co's Q2 2025 Portfolio in Review
As of Q2 2025, D.E. Shaw & Co held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- D.E. Shaw & Co's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- D.E. Shaw & Co added most to Apple in Q2 2025, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- D.E. Shaw & Co fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- D.E. Shaw & Co opened 647 new positions and closed 532 in Q2 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.